⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL29001621 | 0.98 | FDPS (0.44) | — | |
| Acetic Acid SCHEMBL29250458 | 0.93 | FFAR2 (0.43) | — | |
| Fluorobenzene SCHEMBL27924969 | 0.85 | CYP3A4 (0.44) | — | |
| SCHEMBL8819697 | 0.83 | FDPS (0.48) | — | |
| SCHEMBL7342758 | 0.83 | FDPS (0.48) | — | |
| SCHEMBL5333624 | 0.81 | FDPS (0.41) | — | |
| SCHEMBL170782 | 0.81 | — | — | |
| SCHEMBL1906545 | 0.79 | — | — | |
| SCHEMBL2018066 | 0.79 | — | — | |
| SCHEMBL28057416 | 0.79 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116102688-B | Zwitterionic polymer hydrogel and preparation method and application thereof | 武汉科技大学 | 2025-03-04 | — | — | CN | claimed |
| CN-116102688-A | Zwitterionic polymer hydrogel and preparation method and application thereof | 武汉科技大学 | 2023-05-12 | — | — | CN | claimed |
| CN-112844472-A | Preparation method and application of chiral imidazole urea catalyst | 深圳飞扬兴业科技有限公司 | 2021-05-28 | — | — | CN | claimed |
| CN-107922611-B | Imidazoyl urea polymers and their use in metal or metal alloy plating bath compositions | 埃托特克德国有限公司 | 2020-11-24 | — | — | CN | claimed |
| EP-3708676-A1 | PRESERVATION OF FETAL NUCLEIC ACIDS IN MATERNAL PLASMA | Streck, Inc. (US) | 2020-09-16 | — | — | EP | claimed |
| WO-2016010984-A2 | COMPOSITIONS AND METHODS FOR TREATING ROSACEA | TISSUE TECH, INC. (US) | 2016-01-21 | — | — | WO | claimed |
| US-20160008295-A1 | COMPOSITIONS AND METHODS FOR TREATING ROSACEA | TISSUE TECH, INC. | 2016-01-14 | — | — | US | claimed |
| EP-2626438-A1 | Preservation of fetal nucleic acids in maternal plasma | Streck Inc. (US) | 2013-08-14 | — | — | EP | claimed |
| US-20120295940-A1 | COMPOSITIONS FOR TREATING MASTITIS | NOBLE ION, LLC (US) | 2012-11-22 | — | — | US | claimed |
| US-20100298386-A1 | COMPOSITIONS AND METHODS FOR TREATING MASTITIS | BYOCOAT ENTERPRISES, INC. (PR) | 2010-11-25 | — | — | US | claimed |
| US-20090233914-A1 | Composition for treatment of nail infections | ONDINE INTERNATIONAL, LTD. | 2009-09-17 | — | — | US | claimed |
| US-20090170876-A1 | Novel Topical Formulations of Flucytosine | CAMARGO PHARMACEUTICAL SERVICES, LLC (US) | 2009-07-02 | — | — | US | claimed |
| WO-2009045456-A1 | COMPOSITIONS AND METHODS FOR TREATING MASTITIS | BYOCOAT ENTERPRISES, INC. (PR) | 2009-04-09 | — | — | WO | claimed |
| US-20090068287-A1 | Novel topical formulations of flucytosine and uses thereof | CAMARGO PHARMACEUTICAL SERVICES LLC | 2009-03-12 | — | — | US | claimed |
| WO-2008109424-A1 | COMPOSITION, THERAPY AND DEVICE FOR TREATMENT OF NAIL INFECTIONS | ONDINE INTERNATIONAL LTD. (BB) | 2008-09-12 | — | — | WO | claimed |
| US-5922331-A | PROTECTION AGAINST LUMPINESS, EDEMA AND OTHER EFFECTS FO LIPOSUCTION AND COSMETIC SURGERY | CHANEL, INC. (US) | 1999-07-13 | — | — | US | claimed |
| EP-0029663-B1 | N-ARYL-N'-IMIDAZOL-2-YLUREAS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | McNeilab, Inc. (US) | 1984-04-18 | — | — | EP | claimed |
| EP-0029663-A1 | N-aryl-N'-imidazol-2-ylureas, process for their preparation and pharmaceutical compositions containing them | McNeilab, Inc. (US) | 1981-06-03 | — | — | EP | claimed |
| US-4265900-A | HYPOTENSIVE, ANTISECRETORY, ANTIDIARRHEA | MCNEILAB, INC. (US) | 1981-05-05 | — | — | US | claimed |
| JP-63030471-A | — | — | None | — | — | JP | disclosed |
| EP-4572738-A1 | SOFT-FOCUS COSMETICS COMPOSITIONS AND METHODS FOR REDUCING THE APPEARANCE OF SKIN IMPERFECTIONS | ELC Management LLC (US) | 2025-06-25 | — | — | EP | disclosed |
| CN-119663385-A | Leveling agent and preparation method thereof, copper electroplating solution and copper electroplating method | 广东东硕科技有限公司 | 2025-03-21 | — | — | CN | disclosed |
| CN-116102688-B | Zwitterionic polymer hydrogel and preparation method and application thereof | 武汉科技大学 | 2025-03-04 | — | — | CN | disclosed |
| CN-119060277-A | Latent curing agent and preparation method and application thereof | 株洲市弘大新材料有限公司 | 2024-12-03 | — | — | CN | disclosed |
| US-20240299561-A1 | HISTIDINE-SELECTIVE POLYMER REAGENTS | NEKTAR THERAPEUTICS | 2024-09-12 | — | — | US | disclosed |
| EP-4355371-A1 | HISTIDINE-SELECTIVE POLYMER REAGENTS | Nektar Therapeutics (US) | 2024-04-24 | — | — | EP | disclosed |
| WO-2024039497-A1 | SOFT-FOCUS COSMETICS COMPOSITIONS AND METHODS FOR REDUCING THE APPEARANCE OF SKIN IMPERFECTIONS | ELC MANAGEMENT LLC (US) | 2024-02-22 | — | — | WO | disclosed |
| CN-117425470-A | Antiperspirant compositions | 科蒂公司 | 2024-01-19 | — | — | CN | disclosed |
| CN-116940326-A | Antiperspirant compositions | 科蒂公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116035935-B | Anti-dandruff and antipruritic composition and preparation method thereof, shampoo and preparation method thereof, and medicament | 肇庆迪彩日化科技有限公司 | 2023-09-19 | — | — | CN | disclosed |
| EP-4032930-B1 | BIURET-BASED QUATERNIZED POLYMERS AND THEIR USE IN METAL OR METAL ALLOY PLATING BATHS | ATOTECH DEUTSCHLAND GMBH & CO KG (DE) | 2023-08-30 | — | — | EP | disclosed |
| CN-116621781-A | Preparation method of 2- (3-nitrophenyl) -4, 5-dihydro-1H-imidazoline | 济南鸿湾生物技术有限公司 | 2023-08-22 | — | — | CN | disclosed |
| CN-116355172-A | Polyurethane elastomer and preparation method thereof | 东华大学 | 2023-06-30 | — | — | CN | disclosed |
| CN-116367811-A | Antiperspirant compositions | 科蒂公司 | 2023-06-30 | — | — | CN | disclosed |
| CN-116042114-B | Holographic anti-counterfeiting packaging film and printing process thereof | 汕头市恒顺包装材料有限公司 | 2023-06-20 | — | — | CN | disclosed |
| CN-116102688-A | Zwitterionic polymer hydrogel and preparation method and application thereof | 武汉科技大学 | 2023-05-12 | — | — | CN | disclosed |
| CN-116042114-A | Holographic anti-counterfeiting packaging film and printing process thereof | 汕头市恒顺包装材料有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-116035935-A | Anti-dandruff and antipruritic composition and preparation method thereof, shampoo and preparation method thereof, and medicament | 肇庆迪彩日化科技有限公司 | 2023-05-02 | — | — | CN | disclosed |
| CN-115926109-A | Imidazole urea bond self-healing elastomer based on copper ion coordination | 东华大学 | 2023-04-07 | — | — | CN | disclosed |
| WO-2022266498-A1 | HISTIDINE-SELECTIVE POLYMER REAGENTS | NEKTAR THERAPEUTICS (US) | 2022-12-22 | — | — | WO | disclosed |
| WO-2022157292-A1 | BIURET-BASED QUATERNIZED POLYMERS AND THEIR USE IN METAL OR METAL ALLOY PLATING BATHS | Atotech Deutschland GmbH & Co. KG (DE) | 2022-07-28 | — | — | WO | disclosed |
| EP-4032930-A1 | BIURET-BASED QUATERNIZED POLYMERS AND THEIR USE IN METAL OR METAL ALLOY PLATING BATHS | Atotech Deutschland GmbH & Co. KG (DE) | 2022-07-27 | — | — | EP | disclosed |
| WO-2022125592-A1 | METHODS OF MAKING WATER-SOLUBLE PROTEIN FORMED IN A BACTERIAL EXPRESSION SYSTEM, COMPOSITIONS, AND METHODS OF USE THEREOF | The Research Foundation for the State Universtiy of New York (US) | 2022-06-16 | — | — | WO | disclosed |
| CN-111995683-B | anti-PD-L1 protein monoclonal antibody, cell strain, preparation method and application thereof | 福州迈新生物技术开发有限公司 | 2022-03-11 | — | — | CN | disclosed |
| CN-107406339-B | Method and apparatus for producing alpha-olefin oligomer | 三菱化学株式会社 | 2021-10-26 | — | — | CN | disclosed |
| US-11130737-B2 | Multifunctional aminoquinoline therapeutic agents | LOHOCLA RESEARCH CORPORATION (US) | 2021-09-28 | — | — | US | disclosed |
| EP-3846813-A1 | ANALGESIC COMPOSITIONS | Lohocla Research Corporation (US) | 2021-07-14 | — | — | EP | disclosed |
| EP-1613613-B1 | CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS | GENZYME CORP (US) | 2021-06-02 | — | — | EP | disclosed |
| US-10953021-B2 | Topical compositions of flunisolide and methods of treatment | LUPIN LIMITED (IN) | 2021-03-23 | — | — | US | disclosed |
| CN-111995683-A | anti-PD-L1 protein monoclonal antibody, cell strain, preparation method and application thereof | 福州迈新生物技术开发有限公司 | 2020-11-27 | — | — | CN | disclosed |
| CN-107922611-B | Imidazoyl urea polymers and their use in metal or metal alloy plating bath compositions | 埃托特克德国有限公司 | 2020-11-24 | — | — | CN | disclosed |
| CN-107074679-B | Method and apparatus for producing alpha-olefin oligomer | 三菱化学株式会社 | 2020-11-17 | — | — | CN | disclosed |
| CN-107406345-B | Process for producing alpha-olefin oligomer | 三菱化学株式会社 | 2020-08-11 | — | — | CN | disclosed |
| CN-107428629-B | α -Process for producing olefin oligomer | 三菱化学株式会社 | 2020-07-28 | — | — | CN | disclosed |
| US-20200095204-A1 | MULTIFUNCTIONAL AMINOQUINOLINE THERAPEUTIC AGENTS | LOHOCLA RESEARCH CORPORATION | 2020-03-26 | — | — | US | disclosed |
| US-20190321395-A1 | TREATMENT OF PSORIASIS, SEBORRHEIC DERMATITIS, AND ECZEMA OF THE HEAD AND NECK | Oread Therapeutics | 2019-10-24 | — | — | US | disclosed |
| US-10441522-B2 | Surfactant-containing cleaning agent compositions with specific combinations of four preservatives | HENKEL AG & CO. KGAA (DE) | 2019-10-15 | — | — | US | disclosed |
| US-10435371-B2 | Multifunctional aminoquinoline therapeutic agent | LOHOCLA RESEARCH CORPORATION (US) | 2019-10-08 | — | — | US | disclosed |
| US-10391088-B2 | Analgesic compositions | LOHOCLA RESEARCH CORPORATION (US) | 2019-08-27 | — | — | US | disclosed |
| US-10357442-B2 | Surfactant-containing cleansing agents with at least four different preservatives | HENKEL AG & CO. KGAA (DE) | 2019-07-23 | — | — | US | disclosed |
| US-20190099412-A1 | ANALGESIC COMPOSITIONS | LOHOCLA RESEARCH CORPORATION | 2019-04-04 | — | — | US | disclosed |
| US-20190092731-A1 | MULTIFUNCAIONAL AMINOQUINOLINE THERAPEUTIC AGENT | LOHOCLA RESEARCH CORPORATION | 2019-03-28 | — | — | US | disclosed |
| US-10155788-B2 | Cationic steroidal antimicrobial prodrug compositions and uses thereof | BRIGHAM YOUNG UNIVERSITY (US) | 2018-12-18 | — | — | US | disclosed |
| US-10112905-B2 | Multifunctional aminoquinoline therapeutic agents | LOHOCLA RESEARCH CORPORATION (US) | 2018-10-30 | — | — | US | disclosed |
| CN-107428629-A | Process for producing alpha-olefin oligomer | 三菱化学株式会社 | 2017-12-01 | — | — | CN | disclosed |
| US-9827195-B2 | Fatty acid pharmaceutical foam | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2017-11-28 | — | — | US | disclosed |
| CN-107406339-A | Method and apparatus for producing alpha-olefin oligomer | 三菱化学株式会社 | 2017-11-28 | — | — | CN | disclosed |
| CN-107406345-A | Process for producing alpha-olefin oligomer | 三菱化学株式会社 | 2017-11-28 | — | — | CN | disclosed |
| EP-3209271-A1 | METHOD OF IMPROVED VOLUME AND COMBABILITY USING PERSONAL CARE COMPOSITION COMPRISING A PRE-EMULSIFIED FORMULATION | The Procter and Gamble Company (US) | 2017-08-30 | — | — | EP | disclosed |
| CN-107074679-A | Method and apparatus for producing alpha-olefin oligomer | 三菱化学株式会社 | 2017-08-18 | — | — | CN | disclosed |
| US-20170204064-A1 | MULTIFUNCTIONAL AMINOQUINOLINE THERAPEUTIC AGENTS | LOHOCLA RESEARCH CORPORATION | 2017-07-20 | — | — | US | disclosed |
| US-20170172871-A1 | PROPELLANT-INCLUDING DEODORANTS AND/OR ANTIPERSPIRANTS COMPRISING AT LEAST TWO DIFFERENT PRESERVATIVES | HENKEL AG & CO. KGAA (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170172894-A1 | PROPELLANT-FREE DEODORANTS AND/OR ANTIPERSPIRANTS COMPRISING AT LEAST TWO DIFFERENT PRESERVATIVES | HENKEL AG & CO. KGAA (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170172872-A1 | PROPELLANT-FREE DEODORANTS AND/OR ANTIPERSPIRANTS HAVING SPECIFIC PRESERVATIVE-AGENT COMBINATIONS | HENKEL AG & CO. KGAA (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170172873-A1 | PROPELLANT-FREE DEODORANTS AND/OR ANTIPERSPIRANTS HAVING SPECIFIC PRESERVATIVE-AGENT COMBINATIONS | HENKEL AG & CO. KGAA (DE) | 2017-06-22 | — | — | US | disclosed |
| US-20170165167-A1 | SURFACTANT-CONTAINING CLEANING AGENT COMPOSITIONS WITH SPECIFIC PRESERVATIVE COMBINATIONS | HENKEL AG & CO. KGAA (DE) | 2017-06-15 | — | — | US | disclosed |
| US-20170165168-A1 | EMULSIONS INCLUDING AT LEAST ONE SPECIAL PRESERVATIVE COMBINATION | HENKEL AG & CO. KGAA (DE) | 2017-06-15 | — | — | US | disclosed |
| US-20170165169-A1 | SURFACTANT-CONTAINING CLEANSING AGENTS WITH AT LEAST THREE DIFFERENT PRESERVATIVES | HENKEL AG & CO. KGAA (DE) | 2017-06-15 | — | — | US | disclosed |
| EP-3157523-A1 | MULTIFUNCTIONAL AMINOQUINOLINE THERAPEUTIC AGENTS | Lohocla Research Corporation (US) | 2017-04-26 | — | — | EP | disclosed |
| US-9314524-B2 | Topical formulations of Flucytosine | CALLA THERAPEUTICS LLC (US) | 2016-04-19 | — | — | US | disclosed |
| WO-2016057635-A1 | CATIONIC STEROIDAL ANTIMICROBIAL PRODRUG COMPOSITIONS AND USES THEREOF | SAVAGE PAUL B (US) | 2016-04-14 | — | — | WO | disclosed |
| US-20160096864-A1 | CATIONIC STEROIDAL ANTIMICROBIAL PRODRUG COMPOSITIONS AND USES THEREOF | BRIGHAM YOUNG UNIVERSITY (US) | 2016-04-07 | — | — | US | disclosed |
| WO-2016054450-A1 | METHOD OF IMPROVED VOLUME AND COMBABILITY USING PERSONAL CARE COMPOSITION COMPRISING A PRE-EMULSIFIED FORMULATION | THE PROCTER & GAMBLE COMPANY (US) | 2016-04-07 | — | — | WO | disclosed |
| WO-2016010984-A2 | COMPOSITIONS AND METHODS FOR TREATING ROSACEA | TISSUE TECH, INC. (US) | 2016-01-21 | — | — | WO | disclosed |
| EP-2968572-A1 | TOPICAL COMPOSITIONS OF FLUNISOLIDE AND METHODS OF TREATMENT | Medicis Pharmaceutical Corporation (US) | 2016-01-20 | — | — | EP | disclosed |
| US-20160008295-A1 | COMPOSITIONS AND METHODS FOR TREATING ROSACEA | TISSUE TECH, INC. | 2016-01-14 | — | — | US | disclosed |
| WO-2015195943-A1 | MULTIFUNCTIONAL AMINOQUINOLINE THERAPEUTIC AGENTS | LOHOCLA RESEARCH CORPORATION (US) | 2015-12-23 | — | — | WO | disclosed |
| US-20150335617-A1 | METHODS AND COMPOSITIONS FOR TREATING PSORIASIS | NATROGEN THERAPEUTICS INTERNATIONAL, INC. | 2015-11-26 | — | — | US | disclosed |
| CN-102781884-B | Process for producing alpha-olefin oligomer | MITSUBISHI CHEMICAL CORP. (JP) | 2015-11-25 | — | — | CN | disclosed |
| CN-104926589-A | Process for producing alpha-olefin oligomer | MITSUBISHI CHEM CORP | 2015-09-23 | — | — | CN | disclosed |
| US-20150209280-A1 | FATTY ACID PHARMACEUTICAL FOAM | STIEFEL RES AUSTRALIA PTY LTD (AU) | 2015-07-30 | — | — | US | disclosed |
| US-20150202139-A1 | ANTI-AGING SKINCARE PRODUCTS | MD SOLARCIENCES CORP. (US) | 2015-07-23 | — | — | US | disclosed |
| EP-2157091-B1 | Inhibitors of phosphatidylinositol 3-kinase | NOVARTIS AG (CH) | 2015-06-10 | — | — | EP | disclosed |
| US-9023863-B2 | Fatty acid pharmaceutical foam | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2015-05-05 | — | — | US | disclosed |
| CN-104434572-A | Mascara | WANG YUMEI | 2015-03-25 | — | — | CN | disclosed |
| WO-2014145067-A1 | TOPICAL COMPOSITIONS OF FLUNISOLIDE AND METHODS OF TREATMENT | MEDICIS PHARMACEUTICAL CORPORATION (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140274982-A1 | TOPICAL COMPOSITIONS OF FLUNISOLIDE AND METHODS OF TREATMENT | MEDICIS PHARMACEUTICAL CORPORATION (US) | 2014-09-18 | — | — | US | disclosed |
| CN-101864027-B | Copolymers and their use in personal care compositions | CIBA SPECIALTY CHEMICALS HODIN | 2014-08-27 | — | — | CN | disclosed |
| US-8765934-B2 | Methods for conjugating nucleic acids with small molecules | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2014-07-01 | — | — | US | disclosed |
| US-20130338098-A1 | Topical Analgesic Compositions Containing Aliphatic Polyamines and Methods of Using Same | DERMAL THERAPY (BARBADOS) INC. (BB) | 2013-12-19 | — | — | US | disclosed |
| EP-2322525-B1 | Purine derivatives for use as adenosin A2A receptor agonists | NOVARTIS AG (CH) | 2013-09-18 | — | — | EP | disclosed |
| US-20130225581-A1 | NITROGEN-CONTAINING AROMATIC HETEROCYCLIC DERIVATIVE | KYOWA HAKKO KIRIN CO., LTD (JP) | 2013-08-29 | — | — | US | disclosed |
| US-20130172349-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE | NOVARTIS AG (CH) | 2013-07-04 | — | — | US | disclosed |
| US-8470813-B2 | Thiazoline and oxazoline derivatives and their methods of use | ABBVIE INC. (US) | 2013-06-25 | — | — | US | disclosed |
| EP-2594566-A1 | NITROGENATED AROMATIC HETEROCYCLIC RING DERIVATIVE | Kyowa Hakko Kirin Co., Ltd. (JP) | 2013-05-22 | — | — | EP | disclosed |
| US-8445509-B2 | Fused heterocyclic derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-05-21 | — | — | US | disclosed |
| CN-103003262-A | Nitrogenated aromatic heterocyclic ring derivative | KYOWA HAKKO KIRIN CO LTD | 2013-03-27 | — | — | CN | disclosed |
| US-8404684-B2 | Inhibitors of phosphatidylinositol 3-kinase | NOVARTIS AG (CH) | 2013-03-26 | — | — | US | disclosed |
| US-8318750-B2 | Organic compounds | NOVARTIS AG (NL) | 2012-11-27 | — | — | US | disclosed |
| US-20120295940-A1 | COMPOSITIONS FOR TREATING MASTITIS | NOBLE ION, LLC (US) | 2012-11-22 | — | — | US | disclosed |
| CN-102781884-A | Process for producing alpha-olefin oligomer | MITSUBISHI CHEM CORP | 2012-11-14 | — | — | CN | disclosed |
| US-8304557-B2 | Fused heterocycle derivatives and use thereof | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2012-11-06 | — | — | US | disclosed |
| US-8258141-B2 | Organic compounds | NOVARTIS AG (CH) | 2012-09-04 | — | — | US | disclosed |
| EP-1805181-B1 | PURINE DERIVATIVES FOR USE AS ADENOSIN A-2A RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2012-08-29 | — | — | EP | disclosed |
| EP-2046121-B1 | FATTY ACID PHARMACEUTICAL FOAM | STIEFEL RES AUSTRALIA PTY LTD (AU) | 2012-08-22 | — | — | EP | disclosed |
| US-20120177573-A1 | METHODS FOR CONJUGATING NUCLEIC ACIDS WITH SMALL MOLECULES | KAOHSIUNG MEDICAL UNIVERSITY (TW) | 2012-07-12 | — | — | US | disclosed |
| US-8163754-B2 | inflammatory or obstructive airways diseases; in combination with an antiinflammatory, bronchodilatory, antihistamine or anti-tussive; N-[4-(6-Amino-2-phenethylamino-purin-9-yl)-2,3-dihydroxy-cyclopentyl]-propionamide | NOVARTIS AG (CH) | 2012-04-24 | — | — | US | disclosed |
| US-20120070518-A1 | METHODS AND COMPOSITIONS FOR TREATING PSORIASIS | NATROGEN THERAPEUTICS INTERNATIONAL, INC. (US) | 2012-03-22 | — | — | US | disclosed |
| EP-2013211-B1 | PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2012-03-14 | — | — | EP | disclosed |
| US-20120004212-A1 | ORGANIC COMPOUNDS | NOVARTIS AG | 2012-01-05 | — | — | US | disclosed |
| US-20120004247-A1 | ORGANIC COMPOUNDS | NOVARTIS AG | 2012-01-05 | — | — | US | disclosed |
| EP-1633368-B1 | FOAMABLE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A DISORDER | STIEFEL LABORATORIES (US) | 2011-11-16 | — | — | EP | disclosed |
| WO-2011066182-A3 | SOCS3 INHIBITION PROMOTES CNS NEURON REGENERATION | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2011-10-27 | — | — | WO | disclosed |
| US-20110201578-A1 | COMPOSITION AND METHODS FOR THE TREATMENT OF PSEUDOFOLLICULITIS BARBAE AND SKIN IRRITATION | MAN-CHEM, LLC | 2011-08-18 | — | — | US | disclosed |
| US-7998990-B2 | 5-phenyl-thiazol-2-yl-urea derivatives and use as PI3 kinase inhibitors | NOVARTIS AG (CH) | 2011-08-16 | — | — | US | disclosed |
| US-20110124693-A1 | 5-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES | NOVARTIS AG (CH) | 2011-05-26 | — | — | US | disclosed |
| US-20110124624-A1 | 5-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY DISEASES | NOVARTIS AG (CH) | 2011-05-26 | — | — | US | disclosed |
| EP-2322525-A1 | Purine derivatives for use as adenosin A2A receptor agonists | Novartis AG (CH) | 2011-05-18 | — | — | EP | disclosed |
| US-20110105535-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE | NOVARTIS AG | 2011-05-05 | — | — | US | disclosed |
| US-20110091552-A1 | Use of Bcl Inhibitors for the Treatment of Scarring Caused By Cutaneous Wounds, Burns and Abrasions | MCCAFFREY TIM | 2011-04-21 | — | — | US | disclosed |
| US-20110092493-A1 | Dose-controlled transdermal promethazine compositions and methods of use | LEVI CLARK | 2011-04-21 | — | — | US | disclosed |
| EP-2292619-A1 | Purine derivatives for use as adenonsin A-2A receptor agonists | Novartis AG (CH) | 2011-03-09 | — | — | EP | disclosed |
| US-7902375-B2 | Antiallergens; antiarthritic agents; psoriasis; inflammatory bowel disorders; Crohn's disease; sepsis ; antiproliferative agents; anticancer agents; transplant rejection; stroke; antidiabetic agents; restenosis | NOVARTIS AG (CH) | 2011-03-08 | — | — | US | disclosed |
| US-20110046169-A1 | FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-02-24 | — | — | US | disclosed |
| US-20110021630-A1 | METHOD FOR TREATING WOUNDS BY ADMINISTERING FULLERENES | KEPLEY CHRISTOPHER L | 2011-01-27 | — | — | US | disclosed |
| US-20110009486-A1 | METHOD FOR TREATING PRURITUS BY ADMINISTERING FULLERENES | LUNA INNOVATIONS INCORPORATED (US) | 2011-01-13 | — | — | US | disclosed |
| US-20110003773-A1 | USING FULLERENES TO ENHANCE AND STIMULATE HAIR GROWTH | LUNA INNOVATIONS INCORPORATED (US) | 2011-01-06 | — | — | US | disclosed |
| US-20100298386-A1 | COMPOSITIONS AND METHODS FOR TREATING MASTITIS | BYOCOAT ENTERPRISES, INC. (PR) | 2010-11-25 | — | — | US | disclosed |
| US-7833331-B2 | Non-toxic corrosion-protection pigments based on cobalt | UNIVERSITY OF DAYTON (US) | 2010-11-16 | — | — | US | disclosed |
| US-20100286126-A1 | Organic Compounds | NOVARTIS AG (CH) | 2010-11-11 | — | — | US | disclosed |
| US-7829107-B2 | Foamable pharmaceutical compositions and methods for treating a disorder | STIEFEL LABORATORIES, INC. (US) | 2010-11-09 | — | — | US | disclosed |
| US-20100266517-A1 | Two-Coat Cosmetic Compositions | AVON PRODUCTS. INC. (US) | 2010-10-21 | — | — | US | disclosed |
| CN-101864027-A | Multipolymer and the application in personal care composition thereof | CIBA SPECIALTY CHEMICALS HODIN | 2010-10-20 | — | — | CN | disclosed |
| US-7799810-B2 | Organic compounds | NOVARTIS AG (CH) | 2010-09-21 | — | — | US | disclosed |
| US-7789958-B2 | Non-toxic corrosion-protection pigments based on manganese | UNIVERSITY OF DAYTON (US) | 2010-09-07 | — | — | US | disclosed |
| US-20100190776-A1 | Thiazoline and Oxazoline Derivatives and Their Methods of Use | ABBOTT LABORATORIES (US) | 2010-07-29 | — | — | US | disclosed |
| US-20100120865-A1 | Organic compounds | NOVARTIS AG (CH) | 2010-05-13 | — | — | US | disclosed |
| WO-2010036945-A2 | NANOEMULSION THERAPEUTIC COMPOSITIONS AND METHODS OF USING THE SAME | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2010-04-01 | — | — | WO | disclosed |
| US-7683084-B2 | Thiazoline and oxazoline derivatives and their methods of use | ABBOTT LABORATORIES (US) | 2010-03-23 | — | — | US | disclosed |
| EP-2162445-A1 | HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS | Takeda Pharmaceutical Company Limited (JP) | 2010-03-17 | — | — | EP | disclosed |
| EP-2157091-A1 | Inhibitors of phosphatidylinositol 3-kinase | Novartis AG (CH) | 2010-02-24 | — | — | EP | disclosed |
| CN-100577726-C | Polymer emulsions resistant to biodeterioration | WACKER CHEMICAL CORP | 2010-01-06 | — | — | CN | disclosed |
| WO-2009136663-A1 | FUSED HETEROCYCLIC DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-11-12 | — | — | WO | disclosed |
| US-20090281127-A1 | Organic Compounds | NOVARTIS AG (CH) | 2009-11-12 | — | — | US | disclosed |
| EP-1622897-B1 | INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE | NOVARTIS AG (CH) | 2009-10-14 | — | — | EP | disclosed |
| US-20090240045-A1 | Organic Compounds | NOVARTIS AG | 2009-09-24 | — | — | US | disclosed |
| US-20090234132-A1 | 5-PHENYL-THIAZOL-2-YL-UREA DERIVATIVES AND USE AS PI3 KINASE INHIBITORS | NOVARTIS AG (CH) | 2009-09-17 | — | — | US | disclosed |
| US-20090234270-A1 | Therapy and device for treatment of nail infections | ONDINE INTERNATIONAL, LTD. | 2009-09-17 | — | — | US | disclosed |
| US-20090233914-A1 | Composition for treatment of nail infections | ONDINE INTERNATIONAL, LTD. | 2009-09-17 | — | — | US | disclosed |
| WO-2009114089-A2 | USING FULLERENES TO ENHANCE AND STIMULATE HAIR GROWTH | LUNA INNOVATIONS INCORPORATED (US) | 2009-09-17 | — | — | WO | disclosed |
| WO-2009114084-A2 | METHOD FOR TREATING WOUNDS BY ADMINISTERING FULLERENES | LUNA INNOVATIONS INCORPORATED (US) | 2009-09-17 | — | — | WO | disclosed |
| WO-2009114087-A2 | A METHOD FOR TREATING PRURITUS BY ADMINISTERING FULLERENES | LUNA INNOVATIONS INCORPORATED (US) | 2009-09-17 | — | — | WO | disclosed |
| EP-2089052-A1 | PEG LINKER COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES THEREOF | Peg Biosciences (US) | 2009-08-19 | — | — | EP | disclosed |
| US-20090170876-A1 | Novel Topical Formulations of Flucytosine | CAMARGO PHARMACEUTICAL SERVICES, LLC (US) | 2009-07-02 | — | — | US | disclosed |
| US-7553646-B2 | Microbial sulfoxidation and amidation of benzhdrylsulfanyl carboxylic acids and uses thereof | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2009-06-30 | — | — | US | disclosed |
| US-20090163628-A1 | NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON COBALT | STURGILL JEFFREY ALLEN | 2009-06-25 | — | — | US | disclosed |
| US-20090163488-A1 | FUSED HETEROCYCLE DERIVATIVES AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2009-06-25 | — | — | US | disclosed |
| US-20090105476-A1 | Organic Compounds | NOVARTIS AG | 2009-04-23 | — | — | US | disclosed |
| US-20090105195-A1 | COMPOSITION COMPRISING MICROBICIDAL ACTIVE INGREDIENTS | NUGENE BIOPHARMA, INC | 2009-04-23 | — | — | US | disclosed |
| EP-1689391-B1 | 5-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY AIRWAY DISEASES | NOVARTIS AG (CH) | 2009-04-22 | — | — | EP | disclosed |
| US-20090099214-A1 | Organic Compounds | NOVARTIS AG | 2009-04-16 | — | — | US | disclosed |
| EP-2046121-A2 | FATTY ACID PHARMACEUTICAL FOAM | Stiefel Research Australia Pty Ltd (AU) | 2009-04-15 | — | — | EP | disclosed |
| WO-2009045456-A1 | COMPOSITIONS AND METHODS FOR TREATING MASTITIS | BYOCOAT ENTERPRISES, INC. (PR) | 2009-04-09 | — | — | WO | disclosed |
| EP-2038278-A2 | THIAZOLINE AND OXAZOLINE DERIVATIVES AND THEIR METHODS OF USE | Abbott Laboratories (US) | 2009-03-25 | — | — | EP | disclosed |
| EP-2035413-A2 | THIAZOLYL UREA DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | Novartis AG (CH) | 2009-03-18 | — | — | EP | disclosed |
| US-20090068287-A1 | Novel topical formulations of flucytosine and uses thereof | CAMARGO PHARMACEUTICAL SERVICES LLC | 2009-03-12 | — | — | US | disclosed |
| EP-1318801-B1 | TOPICAL ANALGESIC COMPOSITIONS CONTAINING ALIPHATIC POLYAMINES AND METHODS OF USING SAME | DERMAL THERAPY BARBADOS INC (BB) | 2009-03-11 | — | — | EP | disclosed |
| EP-2029562-A1 | 5-PHENYL-THIAZ0L-2-YL-UREA DERIVATIVES AND USE AS PI3 KINASE INHIBITORS | Novartis Ag (CH) | 2009-03-04 | — | — | EP | disclosed |
| EP-2018381-A2 | USE OF 2-(PURIN-9-YL)-TETRAHYDOFURAN-3,4-DIOL DERIVATIVES AS ADENOSINE A2A RECEPTOR AGONISTS | Novartis AG (CH) | 2009-01-28 | — | — | EP | disclosed |
| EP-2012760-A2 | PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS | Novartis AG (CH) | 2009-01-14 | — | — | EP | disclosed |
| EP-2013211-A2 | PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS | Novartis AG (CH) | 2009-01-14 | — | — | EP | disclosed |
| EP-2013210-A1 | PURINE DERIVATIVES WITH ACTIVITY TO THE ADENOSINE A2A RECEPTOR | Novartis Ag (CH) | 2009-01-14 | — | — | EP | disclosed |
| WO-2008152159-A2 | 6 -ACYLOXY- 7-METH0XY- 2, 2 -DIMETHYLCHROMANE COMPOUNDS AND THEIR USE AS PIGMENTATION-REGULATORS | LIPOTEC, S.A. (ES) | 2008-12-18 | — | — | WO | disclosed |
| WO-2008150015-A1 | HETEROBICYCLIC COMPOUNDS AS KINASE INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-12-11 | — | — | WO | disclosed |
| US-20080280871-A1 | 5-Phenyl-4-Methyl-Thiazol-2-Yl-Amine Derivatives as Inhibitors of Phosphatidylin Ositol 3 Kinase Enzymes (PI13) For Treatment of Inflammatory Diseases | NOVARTIS AG (CH) | 2008-11-13 | — | — | US | disclosed |
| EP-1979051-A2 | TWO-COAT COSMETIC COMPOSITIONS | AVON PRODUCTS, INC. (US) | 2008-10-15 | — | — | EP | disclosed |
| US-20080242683-A1 | Organic Compounds | NOVARTIS AG (CH) | 2008-10-02 | — | — | US | disclosed |
| WO-2008109424-A1 | COMPOSITION, THERAPY AND DEVICE FOR TREATMENT OF NAIL INFECTIONS | ONDINE INTERNATIONAL LTD. (BB) | 2008-09-12 | — | — | WO | disclosed |
| US-7422793-B2 | Non-toxic corrosion-protection rinses and seals based on rare earth elements | UNIVERSITY OF DAYTON (US) | 2008-09-09 | — | — | US | disclosed |
| US-20080200483-A1 | Purine Derivatives for Use as Adenosin A-2A Receptor Agonists | NOVARTIS AG (CH) | 2008-08-21 | — | — | US | disclosed |
| US-7407711-B2 | Non-toxic corrosion-protection conversion coats based on rare earth elements | UNIVERSITY OF DAYTON (US) | 2008-08-05 | — | — | US | disclosed |
| US-20080070929-A1 | THIAZOLINE AND OXAZOLINE DERIVATIVES AND THEIR METHODS OF USE | ABBVIE INC. | 2008-03-20 | — | — | US | disclosed |
| US-20080056996-A1 | PHOTODYNAMIC THERAPY FOR THE TREATMENT OF HAIR LOSS | QLT INC. (CA) | 2008-03-06 | — | — | US | disclosed |
| US-20080015271-A1 | Fatty acid pharmaceutical foam | STIEFEL RESEARCH AUSTRIALIA PTY LTD (AU) | 2008-01-17 | — | — | US | disclosed |
| WO-2008008397-A2 | FATTY ACID PHARMACEUTICAL FOAM | STIEFEL RESEARCH AUSTRALIA PTY LTD (AU) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008002956-A2 | THIAZOLINE AND OXAZOLINE DERIVATIVES AND THEIR METHODS OF USE | ABBOTT LABORATORIES (US) | 2008-01-03 | — | — | WO | disclosed |
| WO-2008000421-A2 | THIAZOLYL UREA DERIVATIVES AS PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS | NOVARTIS AG (CH) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007140282-A1 | PEG LINKER COMPOUNDS AND BIOLOGICALLY ACTIVE CONJUGATES THEREOF | PEG BIOSCIENCES (US) | 2007-12-06 | — | — | WO | disclosed |
| EP-1861412-A1 | ADENOSINE DERIVATIVES HAVING A2A RECEPTOR ACTIVITY | Novartis AG (CH) | 2007-12-05 | — | — | EP | disclosed |
| WO-2007134827-A1 | 5-PHENYL-THIAZ0L-2-YL-UREA DERIVATIVES AND USE AS PI3 KINASE INHIBITORS | NOVARTIS AG (CH) | 2007-11-29 | — | — | WO | disclosed |
| CN-101076514-A | Derivatives of arylsulfonamido-substituted hydroxamic acid as matrix metalloproteinases inhibitors | ABIOGEN PHARMA SPA (IT) | 2007-11-21 | — | — | CN | disclosed |
| US-7294211-B2 | Non-toxic corrosion-protection conversion coats based on cobalt | UNIVERSITY OF DAYTON (US) | 2007-11-13 | — | — | US | disclosed |
| US-7291217-B2 | Non-toxic corrosion-protection pigments based on rare earth elements | UNIVERSITY OF DAYTON (US) | 2007-11-06 | — | — | US | disclosed |
| WO-2007121919-A1 | PURINE DERIVATIVES WITH ACTIVITY TO THE ADENOSINE A2A RECEPTOR | NOVARTIS AG (CH) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007121920-A2 | PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007121921-A2 | PURINE DERIVATIVES FOR USE AS ADENOSIN A2A RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007121918-A2 | USE OF 2-(PURIN-9-YL)-TETRAHYDOFURAN-3,4-DIOL DERIVATIVES AS ADENOSINE A2A RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2007-11-01 | — | — | WO | disclosed |
| US-7264629-B2 | Photodynamic therapy for the treatment of hair loss | QLT, INC. (CA) | 2007-09-04 | — | — | US | disclosed |
| WO-2007079155-A2 | TWO-COAT COSMETIC COMPOSITIONS | AVON PRODUCTS, INC. (US) | 2007-07-12 | — | — | WO | disclosed |
| EP-1805181-A1 | PURINE DERIVATIVES FOR USE AS ADENOSIN A-2A RECEPTOR AGONISTS | Novartis AG (CH) | 2007-07-11 | — | — | EP | disclosed |
| US-20070149673-A1 | NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON MANGANESE | STURGILL JEFFREY A | 2007-06-28 | — | — | US | disclosed |
| US-7235142-B2 | Non-toxic corrosion-protection rinses and seals based on cobalt | UNIVERSITY OF DAYTON (US) | 2007-06-26 | — | — | US | disclosed |
| US-20070087047-A1 | Enhanced circulation effector composition and method | ALZA CORPORATION | 2007-04-19 | — | — | US | disclosed |
| US-20070059253-A1 | Foamable pharmaceutical compositions and methods for treating a disorder | STIEFEL LABORATORIES, INC. | 2007-03-15 | — | — | US | disclosed |
| EP-1633368-A4 | FOAMABLE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A DISORDER | STIEFEL LABORATORIES (US) | 2007-03-14 | — | — | EP | disclosed |
| WO-2007027328-A2 | MICROBIAL SULFOXIDATION AND AMIDATION OF BENZHDRYLSULFANYL CARBOXYLIC ACIDS AND USES THEREOF | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2007-03-08 | — | — | WO | disclosed |
| US-7186416-B2 | Foamable pharmaceutical compositions and methods for treating a disorder | STIEFEL LABORATORIES, INC. (US) | 2007-03-06 | — | — | US | disclosed |
| US-20070032487-A1 | Inhibitors of phosphatidylinositol 3-kinase | NOVARTIS AG (CH) | 2007-02-08 | — | — | US | disclosed |
| US-20070026507-A1 | MICROBIAL SULFOXIDATION AND AMIDATION OF BENZHDRYLSULFANYL CARBOXYLIC ACIDS AND USES THEREOF | UNIVERSITY OF IOWA RESEARCH FOUNDATION (US) | 2007-02-01 | — | — | US | disclosed |
| US-7160554-B2 | Enhanced circulation effector composition and method | ALZA CORPORATION (US) | 2007-01-09 | — | — | US | disclosed |
| US-7150882-B2 | Enhanced circulation effector composition and method | ALZA CORPORATION (US) | 2006-12-19 | — | — | US | disclosed |
| US-20060265028-A1 | Hair growth | QLT INC. (CA) | 2006-11-23 | — | — | US | disclosed |
| WO-2006097260-A1 | ADENOSINE DERIVATIVES HAVING A2A RECEPTOR ACTIVITY | NOVARTIS AG (CH) | 2006-09-21 | — | — | WO | disclosed |
| EP-1100454-A4 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MANAGING SKIN CONDITIONS | MURAD HOWARD (US) | 2006-09-20 | — | — | EP | disclosed |
| EP-1689391-A2 | 5-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY AIRWAY DISEASES | Novartis AG (CH) | 2006-08-16 | — | — | EP | disclosed |
| CN-1794998-A | Foamable pharmaceutical compositions and methods for treating a disorder | STIEFEL LABORATORIES (US) | 2006-06-28 | — | — | CN | disclosed |
| WO-2006053172-A2 | THE USE OF ESTRIOL AND OTHER ESTRANES, ESTROGENS AND ESTROGEN RECEPTOR ACTIVE COMPOSITIONS IN THE TREATMENT OF PSORIASIS AND OTHER AUTOIMMUNE DISEASES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2006-05-18 | — | — | WO | disclosed |
| WO-2006045552-A1 | PURINE DERIVATIVES FOR USE AS ADENOSIN A-2A RECEPTOR AGONISTS | NOVARTIS AG (CH) | 2006-05-04 | — | — | WO | disclosed |
| US-20060083708-A1 | Composition using mineral salts for cosmetic or therapeutic treatment | MASADA MARKETING CORP. | 2006-04-20 | — | — | US | disclosed |
| EP-1633368-A2 | FOAMABLE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A DISORDER | STIEFEL LABORATORIES, INC. (US) | 2006-03-15 | — | — | EP | disclosed |
| EP-1622897-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE | Novartis AG (CH) | 2006-02-08 | — | — | EP | disclosed |
| EP-1617909-A1 | HAIR GROWTH | QLT Inc. (CA) | 2006-01-25 | — | — | EP | disclosed |
| US-20050232957-A1 | Compositions and methods for moisturizing skin | TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE | 2005-10-20 | — | — | US | disclosed |
| CN-1678569-A | Photostable cationic organic sunscreen compounds and compositions obtained therefrom | MERCK PATENT GMBH (DE) | 2005-10-05 | — | — | CN | disclosed |
| US-20050209208-A1 | Use of estriol and other estranes, estrogens and estrogen receptor active compositions in the treatment of psoriasis and other autoimmune disorders | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2005-09-22 | — | — | US | disclosed |
| CN-1671759-A | Copolymers and their use in personal care compositions | CIBA SC HOLDING AG (CH) | 2005-09-21 | — | — | CN | disclosed |
| EP-1228107-B1 | ACRYLIC BLOCK COPOLYMER PIGMENT DISPERSANTS CONTAINING HETEROCYCLIC GROUPS | DU PONT (US) | 2005-07-13 | — | — | EP | disclosed |
| US-20050090481-A1 | Compositions comprising a photosensitizer and a skin-penetration enhancer and their use in photodynamic treatment | QLT INC | 2005-04-28 | — | — | US | disclosed |
| CN-1198858-C | Cationic polymers and their use | BASF AG (DE) | 2005-04-27 | — | — | CN | disclosed |
| WO-2005021519-A2 | 5-PHENYL-4-METHYL-THIAZOL-2-YL-AMINE DERIVATIVES AS INHIBITORS OF PHOSPHATIDYLINOSITOL 3 KINASE ENZYMES (PI3) FOR THE TREATMENT OF INFLAMMATORY AIRWAY DISEASES | NOVARTIS AG (CH) | 2005-03-10 | — | — | WO | disclosed |
| US-20040247663-A1 | Liposomes with effector biomolecules attached to the distal ends of hydrophilic polymer chains provide increased time in the bloodstream; polymyxin B used for septic shock | ALZA CORPORATION | 2004-12-09 | — | — | US | disclosed |
| WO-2004105702-A2 | FOAMABLE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING A DISORDER | STIEFEL LABORATORIES, INC. (US) | 2004-12-09 | — | — | WO | disclosed |
| US-20040241099-A1 | Foamable pharmaceutical compositions and methods for treating a disorder | CONNETICS CORPORATION | 2004-12-02 | — | — | US | disclosed |
| CN-1550520-A | Polymer emulsions resistant to biodeterioration | �����Ʒ�ۺ��﹫˾ | 2004-12-01 | — | — | CN | disclosed |
| WO-2004096797-A1 | INHIBITORS OF PHOSPHATIDYLINOSITOL 3-KINASE | NOVARTIS AG (CH) | 2004-11-11 | — | — | WO | disclosed |
| WO-2004093993-A1 | HAIR GROWTH | QLT INC. (CA) | 2004-11-04 | — | — | WO | disclosed |
| EP-1472319-A1 | NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2004-11-03 | — | — | EP | disclosed |
| WO-2004081034-A2 | ALTERING METABOLISM IN BIOLOGICAL PROCESSES | ADVANCED BIOCATALYTICS CORPORATION (US) | 2004-09-23 | — | — | WO | disclosed |
| WO-2004065305-A1 | NON-TOXIC CORROSION-PROTECTION PIGMENTS BASED ON MANGANESE | UNIVERSITY OF DAYTON (US) | 2004-08-05 | — | — | WO | disclosed |
| EP-1441767-A1 | COMPOSITIONS COMPRISING A PHOTOSENSITIZER AND A SKIN-PENETRATION ENHANCER AND THEIR USE IN PHOTODYNAMIC TREATMENT | QLT Inc. (CA) | 2004-08-04 | — | — | EP | disclosed |
| US-20040120990-A1 | Absorbent proteins and methods for using same | CUSHMAN JOHN C (US) | 2004-06-24 | — | — | US | disclosed |
| US-20040104377-A1 | Non-toxic corrosion-protection pigments based on rare earth elements | UNIVERSITY OF DAYTON | 2004-06-03 | — | — | US | disclosed |
| US-20040029856-A1 | Photodynamic therapy for the treatment of hair loss | QLT INC. (CA) | 2004-02-12 | — | — | US | disclosed |
| US-20040020568-A1 | Non-toxic corrosion-protection conversion coats based on rare earth elements | DAYTON, UNIVERSITY OF | 2004-02-05 | — | — | US | disclosed |
| US-20040016910-A1 | Non-toxic corrosion-protection rinses and seals based on rare earth elements | DAYTON, UNIVERSITY OF | 2004-01-29 | — | — | US | disclosed |
| US-20040011252-A1 | Non-toxic corrosion-protection pigments based on manganese | UNIVERSITY OF DAYTON | 2004-01-22 | — | — | US | disclosed |
| US-20030234063-A1 | Non-toxic corrosion-protection conversion coats based on cobalt | DAYTON, UNIVERSITY OF | 2003-12-25 | — | — | US | disclosed |
| US-20030230363-A1 | Non-toxic corrosion-protection rinses and seals based on cobalt | UNIVERSITY OF DAYTON | 2003-12-18 | — | — | US | disclosed |
| US-20030198665-A1 | Enhanced circulation effector composition and method | ALZA CORPORATION | 2003-10-23 | — | — | US | disclosed |
| WO-2003060191-A2 | NON-TOXIC CORROSION-PROTECTION CONVERSION COATINGES ABSED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060192-A1 | NON-TOXIC CORROSION-PROTECTION RINSES AND SEALS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| WO-2003060019-A1 | NON-TOXIC CORROSION PROTECTION PIGMENTS BASED ON COBALT | UNIVERSITY OF DAYTON (US) | 2003-07-24 | — | — | WO | disclosed |
| EP-1324681-A2 | ARTICLE FOR THE DELIVERY OF FOAM PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2003-07-09 | — | — | EP | disclosed |
| US-6586002-B2 | Slow down of renal clearance by parenterally administering a liposome having an outer layer of polyoxyethylene glycol chains; effectors, e.g., Fab fragments, CD4 glycoproteins, covalently attached to the distal ends of the polymer chain | ALZA CORPORATION | 2003-07-01 | — | — | US | disclosed |
| EP-1318801-A2 | TOPICAL ANALGESIC COMPOSITIONS CONTAINING ALIPHATIC POLYAMINES AND METHODS OF USING SAME | Dermal Therapy (Barbados) Inc. (BB) | 2003-06-18 | — | — | EP | disclosed |
| WO-2003039597-A1 | COMPOSITIONS COMPRISING A PHOTOSENSITIZER AND A SKIN-PENETRATION ENHANCER AND THEIR USE IN PHOTODYNAMIC TREATMENT | QLT INC. (CA) | 2003-05-15 | — | — | WO | disclosed |
| US-6547063-B1 | Article for the delivery of foam products | THE PROCTER & GAMBLE COMPANY | 2003-04-15 | — | — | US | disclosed |
| EP-1228107-A1 | ACRYLIC BLOCK COPOLYMER PIGMENT DISPERSANTS CONTAINING HETEROCYCLIC GROUPS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2002-08-07 | — | — | EP | disclosed |
| WO-2002030237-A2 | ARTICLE FOR THE DELIVERY OF FOAM PRODUCTS | THE PROCTER & GAMBLE COMPANY (US) | 2002-04-18 | — | — | WO | disclosed |
| EP-1194437-A1 | DIPHOSPHINE LIGANDS FOR METAL COMPLEXES | Solvias AG (CH) | 2002-04-10 | — | — | EP | disclosed |
| WO-2002024185-A2 | TOPICAL ANALGESIC COMPOSITIONS CONTAINING ALIPHATIC POLYAMINES AND METHODS OF USING SAME | DERMAL THERAPY (BARBADOS) INC. (BB) | 2002-03-28 | — | — | WO | disclosed |
| WO-2002022115-A2 | METHODS AND COMPOSITIONS FOR TREATING NAIL FUNGUS | THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK AT STONY BROOK (US) | 2002-03-21 | — | — | WO | disclosed |
| US-20020012697-A1 | COSMETIC AND TISSUE CLEANSING AND MOISTURIZING COMPOSITION | SCHWARTZ SAM (US) | 2002-01-31 | — | — | US | disclosed |
| EP-1169017-A1 | ANTIMICROBIAL WIPES | THE PROCTER & GAMBLE COMPANY (US) | 2002-01-09 | — | — | EP | disclosed |
| US-6326353-B1 | 123THERAPY FOR SEPTIC SHOCK; ADMINISTERING POLYMYXIN BY INJECTION | SEQUUS PHARMACEUTICALS, INC. | 2001-12-04 | — | — | US | disclosed |
| US-20010043929-A1 | Enhanced circulation effector composition and method | ALZA CORPORATION | 2001-11-22 | — | — | US | disclosed |
| US-6316564-B1 | FACILITATE ATTACHMENT ON A PIGMENT SURFACE AND IMPROVE DISPERSANT EFFICIENCY IN SOLVENT-BORNE PAINT SYSTEMS | E. I. DU PONT DE NEMOURS AND COMPANY | 2001-11-13 | — | — | US | disclosed |
| CN-1313870-A | Cationic polymers and their use | BASF AG (DE) | 2001-09-19 | — | — | CN | disclosed |
| US-6283336-B1 | Article for the delivery of foam products | THE PROCTER & GAMBLE COMPANY | 2001-09-04 | — | — | US | disclosed |
| EP-1100454-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MANAGING SKIN CONDITIONS | Murad, Howard (US) | 2001-05-23 | — | — | EP | disclosed |
| WO-2001025292-A1 | ACRYLIC BLOCK COPOLYMER PIGMENT DISPERSANTS CONTAINING HETEROCYCLIC GROUPS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2001-04-12 | — | — | WO | disclosed |
| WO-2001012133-A2 | COSMETIC COMPOSITIONS WITH SELF-WARMING COMPONENT | UNILEVER PLC (GB) | 2001-02-22 | — | — | WO | disclosed |
| EP-1074245-A2 | Composition using mineral salts for therapeutic treatment | Schwartz, Sam (US) | 2001-02-07 | — | — | EP | disclosed |
| US-6180134-B1 | FOR TREATING SUBJECT WITH SMALL EFFECTOR MOLECULES WHICH ARE NORMALLY SUBJECT TO RAPID RENAL CLEARANCE FROM BLOODSTREAM; FOR TREATING SEPTIC SHOCK, FOR USE IN TREATING INFLAMMATION RELATED TO NEUTROPHIL RECRUITMENT AND TISSUE INFILTRATION | SEQUUS PHARMACEUTICALS, INC. | 2001-01-30 | — | — | US | disclosed |
| WO-2001004131-A1 | DIPHOSPHINE LIGANDS FOR METAL COMPLEXES | SOLVIAS AG (CH) | 2001-01-18 | — | — | WO | disclosed |
| WO-2000061107-A1 | ANTIMICROBIAL | THE PROCTER & GAMBLE COMPANY (US) | 2000-10-19 | — | — | WO | disclosed |
| WO-2000006116-A1 | PHARMACEUTICAL COMPOSITIONS AND METHODS FOR MANAGING SKIN CONDITIONS | MURAD HOWARD (US) | 2000-02-10 | — | — | WO | disclosed |
| WO-1999055815-A1 | IMPROVED UNCOMPLEXED CYCLODEXTRIN COMPOSITIONS FOR ODOR CONTROL | THE PROCTER & GAMBLE COMPANY (US) | 1999-11-04 | — | — | WO | disclosed |
| EP-0937453-A2 | Cosmetic and tissue cleansing and moisturizing composition | Schwartz, Sam (US) | 1999-08-25 | — | — | EP | disclosed |
| EP-0804285-B1 | ENCAPSULATED ACTIVE MATERIALS AND METHOD FOR PREPARING SAME | DOW CHEMICAL CO (US) | 1999-07-28 | — | — | EP | disclosed |
| US-5922331-A | PROTECTION AGAINST LUMPINESS, EDEMA AND OTHER EFFECTS FO LIPOSUCTION AND COSMETIC SURGERY | CHANEL, INC. (US) | 1999-07-13 | — | — | US | disclosed |
| EP-0907352-A1 | METHOD AND COMPOSITION FOR SKIN LIGHTENING | UNILEVER PLC (GB) | 1999-04-14 | — | — | EP | disclosed |
| EP-0689428-B1 | ENHANCED CIRCULATION EFFECTOR COMPOSITION AND METHOD | SEQUUS PHARM INC (US) | 1999-01-20 | — | — | EP | disclosed |
| WO-1998058731-A2 | APPARATUS FOR EXPOSING SUBSTRATES TO GAS-PHASE RADICALS | FLOWGENIX CORPORATION (US) | 1998-12-30 | — | — | WO | disclosed |
| EP-0855895-A1 | LIQUID CRYSTAL COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1998-08-05 | — | — | EP | disclosed |
| WO-1998032790-A1 | POROUS ARTICLES WITH SURFACE FUNCTIONALITY AND USES THEREOF | FLOWGENIX CORPORATION (US) | 1998-07-30 | — | — | WO | disclosed |
| WO-1997047280-A1 | METHOD AND COMPOSITION FOR SKIN LIGHTENING | UNILEVER PLC (GB) | 1997-12-18 | — | — | WO | disclosed |
| EP-0804285-A1 | ENCAPSULATED ACTIVE MATERIALS AND METHOD FOR PREPARING SAME | THE DOW CHEMICAL COMPANY (US) | 1997-11-05 | — | — | EP | disclosed |
| WO-1997014394-A1 | LIQUID CRYSTAL COSMETIC COMPOSITION | UNILEVER PLC (GB) | 1997-04-24 | — | — | WO | disclosed |
| US-5620689-A | ADMINISTERING A SUSPENSION OF LIPOSOMES HAVING A SURFACE COATING OF POLYETHYLENE GLYCOL CHAINS | SEQUUS PHARMACEUUTICALS, INC. (US) | 1997-04-15 | — | — | US | disclosed |
| EP-0761658-A1 | Azole-phenyl urea derivatives as ACAT inhibitors and their production | NIHON NOHYAKU CO., LTD. (JP) | 1997-03-12 | — | — | EP | disclosed |
| US-5601761-A | Encapsulated active materials and method for preparing same | THE DOW CHEMICAL COMPANY (US) | 1997-02-11 | — | — | US | disclosed |
| US-5527528-A | INJECTING LIPOSOMES, CONTAINING ANTITUMOR AGENT, WITH COATING OF ENDCAPPED POLYETHYLENE GLYCOL AND ANTIBODIES TO BIND TUMOR-ASSOCIATED ANTIGENS | SEQUUS PHARMACEUTICALS, INC. (US) | 1996-06-18 | — | — | US | disclosed |
| WO-1996009883-A1 | ENCAPSULATED ACTIVE MATERIALS AND METHOD FOR PREPARING SAME | THE DOW CHEMICAL COMPANY (US) | 1996-04-04 | — | — | WO | disclosed |
| EP-0689428-A1 | ENHANCED CIRCULATION EFFECTOR COMPOSITION AND METHOD | SEQUUS PHARMACEUTICALS, INC. (US) | 1996-01-03 | — | — | EP | disclosed |
| WO-1994022429-A1 | SOLID-TUMOR TREATMENT METHOD | LIPOSOME TECHNOLOGY, INC. (US) | 1994-10-13 | — | — | WO | disclosed |
| WO-1994021235-A1 | ENHANCED CIRCULATION EFFECTOR COMPOSITION AND METHOD | LIPOSOME TECHNOLOGY, INC. (US) | 1994-09-29 | — | — | WO | disclosed |
| WO-1994021281-A1 | POLYMER-POLYPEPTIDE COMPOSITION AND METHOD | LIPOSOME TECHNOLOGY, INC. (US) | 1994-09-29 | — | — | WO | disclosed |
| US-5276038-A | 1-aryl-3-(3,4-dihydro-4-oxo-3-quinazolinyl)urea fungicidal agents | AMERICAN CYANAMID COMPANY (US) | 1994-01-04 | — | — | US | disclosed |
| EP-0282050-B1 | CARBONYL- AND SULPHONYL- DERIVATIVES OF 2-(AMINOALKYLTHIO)- METHYL-1,4-DIHYDROPYRIDINES, A METHOD FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1993-10-06 | — | — | EP | disclosed |
| US-4968732-A | POLYEPOXIDE PREPREGS | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | disclosed |
| US-4968732-A | POLYEPOXIDE PREPREGS | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-11-06 | — | — | US | disclosed |
| US-4931529-A | DICYANDIAMIDE AS HARDENER | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-06-05 | — | — | US | disclosed |
| US-4931529-A | DICYANDIAMIDE AS HARDENER | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-06-05 | — | — | US | disclosed |
| EP-0344468-A1 | Imidazolyl-urea compounds and their use as hardening accelerators in epoxy resin compositions for the production of shaped articles | Witco GmbH (DE) | 1989-12-06 | — | — | EP | disclosed |
| EP-0344468-A1 | Imidazolyl-urea compounds and their use as hardening accelerators in epoxy resin compositions for the production of shaped articles | Witco GmbH (DE) | 1989-12-06 | — | — | EP | disclosed |
| EP-0282050-A1 | Carbonyl- and sulphonyl- derivatives of 2-(aminoalkylthio)- methyl-1,4-dihydropyridines, a method for their preparation and pharmaceutical compositions containing them | BOEHRINGER MANNHEIM ITALIA S.P.A. (IT) | 1988-09-14 | — | — | EP | disclosed |
| JP-S6330471-A | NOVEL IMIDAZOLEUREA COMPOUND, SYNTHESIS THEREOF AND CURING METHOD FOR POLYEPOXY RESIN USING SAID COMPOUND | SHIKOKU CHEM CORP | 1988-02-09 | — | — | JP | disclosed |
| EP-0029663-B1 | N-ARYL-N'-IMIDAZOL-2-YLUREAS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | McNeilab, Inc. (US) | 1984-04-18 | — | — | EP | disclosed |
| US-4412079-A | HERBICIDES, INSECTICIDES, FUNGICIDES, MITICIDES | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1983-10-25 | — | — | US | disclosed |
| EP-0029663-A1 | N-aryl-N'-imidazol-2-ylureas, process for their preparation and pharmaceutical compositions containing them | McNeilab, Inc. (US) | 1981-06-03 | — | — | EP | disclosed |
| US-4265900-A | HYPOTENSIVE, ANTISECRETORY, ANTIDIARRHEA | MCNEILAB, INC. (US) | 1981-05-05 | — | — | US | disclosed |
| US-3972706-A | SUBSTITUTED THIADIAZOL-2-YL-UREAS | ELI LILLY AND COMPANY (US) | 1976-08-03 | — | — | US | disclosed |
| US-3972706-A | SUBSTITUTED THIADIAZOL-2-YL-UREAS | ELI LILLY AND COMPANY (US) | 1976-08-03 | — | — | US | disclosed |